The European Society for Medical Oncology (ESMO) and ASCO are publishing a new edition of the ESMO/ASCO Global Curriculum (GC) with contributions from more than 150 authors. The purpose of the GC is ...

The European Society for Medical Oncology (ESMO) Congress featured findings on overall survival, disparities, and artificial intelligence in cancer research. The top content from the European ...

Lugano, Switzerland, 2 December 2024 – The ESMO Immuno-Oncology Congress 2024 will take place in Geneva, Switzerland, from December 11-13, with an option to attend virtually. Leading experts ...

The firm's confidence is bolstered by recent data presented at the European Society for Medical Oncology (ESMO) concerning CLDN6-targeting ... For instance, five PRs have been recorded for BNT211 ...

The adjustment follows BioNTech's presentation of several updates from its oncology pipeline at the European Society for Medical Oncology (ESMO) conference ... BNT327 (PD-L1xVEGF), BNT113 (HPV16+ ...

The firm's confidence is bolstered by recent data presented at the European Society for Medical Oncology (ESMO) concerning CLDN6 ... five PRs have been recorded for BNT211 across different tumor ...

You can reach Andrew on Signal at drewqjoseph.45. This is the online edition of ESMO in 30 Seconds, a pop-up newsletter from the European Society for Medical Oncology’s annual meeting in ...

Using a scoring system established a decade ago by the European Society of Medical Oncology (ESMO) to identify which approvals provide the highest clinical benefit, the researchers sorted the ...

More than 30,000 people will descend on Barcelona, Spain, this week for the 2024 European Society for Medical Oncology (ESMO) Congress, which runs from September 13 to 17. Since the meeting's ...

At ESMO, we will present clinical data that further support the ... the investigational CAR-T cell therapy BNT211, and the investigational ADC therapy BNT323/DB-1303; the nature and characterization ...